SCM
TGTX icon

Sterling Capital Management’s TG Therapeutics TGTX Stock Holding History

Sterling Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.3K Sell
941
-1
-0.1% -$30 ﹤0.01% 1827
2025
Q4 		$28.1K Buy
942
+590
+168% +$19.3K ﹤0.01% 2052
2025
Q3 		$12.7K Sell
352
-5
-1% -$165 ﹤0.01% 2365
2025
Q2 		$12.8K Buy
357
+212
+146% +$7.89K ﹤0.01% 1978
2025
Q1 		$5.72K Buy
145
+4
+3% +$135 ﹤0.01% 2098
2024
Q4 		$4.24K Sell
141
-1
-0.7% -$29 ﹤0.01% 2534
2024
Q3 		$3.32K Buy
+142
New +$3.1K ﹤0.01% 1941

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return